SLC-0111, an inhibitor of carbonic anhydrase IX, attenuates hepatoblastoma cell viability and migration
Eloranta, Katja; Pihlajoki, Marjut; Liljeström, Emmi; Nousiainen, Ruth; Soini, Tea; Lohi, Jouko; Cairo, Stefano; Wilson, David B.; Parkkila, Seppo; Heikinheimo, Markku (2023-01-26)
Eloranta, Katja
Pihlajoki, Marjut
Liljeström, Emmi
Nousiainen, Ruth
Soini, Tea
Lohi, Jouko
Cairo, Stefano
Wilson, David B.
Parkkila, Seppo
Heikinheimo, Markku
26.01.2023
1118268
Julkaisun pysyvä osoite on
https://urn.fi/URN:NBN:fi:tuni-202304033405
https://urn.fi/URN:NBN:fi:tuni-202304033405
Kuvaus
Peer reviewed
Tiivistelmä
Background: In response to hypoxia, tumor cells undergo transcriptional reprogramming including upregulation of carbonic anhydrase (CA) IX, a metalloenzyme that maintains acid-base balance. CAIX overexpression has been shown to correlate with poor prognosis in various cancers, but the role of this CA isoform in hepatoblastoma (HB) has not been examined. Methods: We surveyed the expression of CAIX in HB specimens and assessed the impact of SLC-0111, a CAIX inhibitor, on cultured HB cells in normoxic and hypoxic conditions. Results: CAIX immunoreactivity was detected in 15 out of 21 archival pathology HB specimens. The CAIX-positive cells clustered in the middle of viable tumor tissue or next to necrotic areas. Tissue expression of CAIX mRNA was associated with metastasis and poor clinical outcome of HB. Hypoxia induced a striking upregulation of CAIX mRNA and protein in three HB cell models: the immortalized human HB cell line HUH6 and patient xenograft-derived lines HB-295 and HB-303. Administration of SLC-0111 abrogated the hypoxia-induced upregulation of CAIX and decreased HB cell viability, both in monolayer and spheroid cultures. In addition, SLC-0111 reduced HB cell motility in a wound healing assay. Transcriptomic changes triggered by SLC-0111 administration differed under normoxic vs. hypoxic conditions, although SLC-0111 elicited upregulation of several tumor suppressor genes under both conditions. Conclusion: Hypoxia induces CAIX expression in HB cells, and the CAIX inhibitor SLC-0111 has in vitro activity against these malignant cells.
Kokoelmat
- TUNICRIS-julkaisut [18569]